4//SEC Filing
Sullivan John F 4
Accession 0000899243-21-005847
CIK 0001756262other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 8:57 AM ET
Size
10.5 KB
Accession
0000899243-21-005847
Insider Transaction Report
Form 4
Sullivan John F
VP of Quality & Engineering
Transactions
- Exercise/Conversion
Common Stock
2021-02-09$0.28/sh+8,600$2,408→ 19,428 total - Sale
Common Stock
2021-02-09$32.78/sh−8,400$275,352→ 11,028 total - Sale
Common Stock
2021-02-09$34.18/sh−200$6,836→ 10,828 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-02-09+8,600→ 0 totalExercise: $0.28Exp: 2023-03-27→ Common Stock (8,600 underlying)
Footnotes (3)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $32.50 to $33.41 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The option is fully vested.
Documents
Issuer
TransMedics Group, Inc.
CIK 0001756262
Entity typeother
Related Parties
1- filerCIK 0001774273
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 8:57 AM ET
- Size
- 10.5 KB